Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FXVB5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,475
Award facts
- Contract value 100% obligated
- $44,474.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $44,474.87 delivery order to AmerisourceBergen Drug Corp for COSENTYX SNRDY 300MG DOSE-2PENML on January 23, 2026, with a completion date of January 26, 2026. The award is structured as a firm fixed-price contract with no set-aside designation, indicating competitive selection among qualified vendors. The place of performance is listed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive pharmaceutical supply vehicle enabling the contractor to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The current delivery order for Cosentyx, a specialty pharmaceutical product, exemplifies the company's role in supplying brand-name prescription medications across multiple therapeutic domains to government healthcare facilities serving active-duty personnel, veterans, and other beneficiaries of federal medical systems.
Quick answers
Who was awarded contract SPE2DR26FXVB5?
SPE2DR26FXVB5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FXVB5 worth?
The government has obligated $44,475 on SPE2DR26FXVB5.
Is contract SPE2DR26FXVB5 an order under another contract?
Yes. SPE2DR26FXVB5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXVB5 competed?
The extent of competition for SPE2DR26FXVB5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award